A Missouri judge on Friday approved a $7.25bn (£5.5bn) settlement resolving lawsuits alleging that “Bayer” weedkiller “Roundup” causes cancer, according to BBC World.
Judge Timothy Boyer described the settlement as “fair, reasonable, and adequate”. “Bayer”, a German biotechnology company, proposed the agreement to resolve the US legal battle.
The nationwide settlement will compensate people who used “Roundup” and have non-Hodgkin lymphoma, as well as those who develop the disease in the future. Payments to participants will range from $10,000 to $165,000, depending on how often they used the product, when they were diagnosed and the severity of their illness.
“Bayer” will make annual payments into a fund for up to 21 years, contributing as much as $7.25bn. The company has already paid roughly $10bn to settle litigation related to “Roundup”.
Some attorneys objected to the settlement, arguing that the funds were insufficient. Boyer said he did not want to delay payments to people who are sick.
“Bayer” denies that “Roundup” causes cancer. The settlement follows a US Supreme Court ruling in June in the company’s favour, which overturned a $1.25m settlement for a Missouri man who blamed “Roundup” and its active ingredient, glyphosate, for his non-Hodgkin lymphoma.
The court ruled 7-2 that “Bayer” cannot be sued in state courts because federal regulations do not require a cancer warning label. The company has faced thousands of claims in state and federal courts from people who allege they developed cancer after using the product.
“Monsanto” developed “Roundup” in the 1970s. The International Agency for Research on Cancer, part of the World Health Organization, identified glyphosate in 2015 as a probable human carcinogen.
“Bayer” and some other regulators, including the US Environmental Protection Agency, have disputed that finding. The issue has led to years of costly litigation in the US, where juries in several states have awarded users of the herbicide billions of dollars.